Cholecystitis resident survival guide: Difference between revisions
No edit summary |
No edit summary |
||
Line 49: | Line 49: | ||
:❑ Hematemesis</div></div></div>|B02=<div style="float: left; text-align: left; line-height: 150% ">❑ Acute vague abdominal pain<br>❑ RUQ mass<br>❑ Jaundice<br>❑ Fever</div>|B03=<div style="float: left; text-align: left; line-height: 150% ">❑ Recurrent biliary type abdominal pain<br>❑ Recurrent abdominal bloating<br>❑ Unstable stool with constipation/diarrhea<br>❑ Weight loss</div>|B04=<div style="float: left; text-align: left; line-height: 150% ">'''Imaging studies:'''<br>[[Cholecystitis ultrasound#Chronic Calculous and Acalculous Cholecystitis|TAUSG]]<BR>[[Cholecystitis CT#Chronic Calculous and Acalculous Cholecystitis|CT abdomen]]<br>[[Cholecystitis other diagnostic studies#Chronic Cholecystitis|HIDA scan]]<br>[[Cholecystitis other diagnostic studies#Chronic Cholecystitis|Cholecystokinin stimulated HIDA scan]]</div>}} | :❑ Hematemesis</div></div></div>|B02=<div style="float: left; text-align: left; line-height: 150% ">❑ Acute vague abdominal pain<br>❑ RUQ mass<br>❑ Jaundice<br>❑ Fever</div>|B03=<div style="float: left; text-align: left; line-height: 150% ">❑ Recurrent biliary type abdominal pain<br>❑ Recurrent abdominal bloating<br>❑ Unstable stool with constipation/diarrhea<br>❑ Weight loss</div>|B04=<div style="float: left; text-align: left; line-height: 150% ">'''Imaging studies:'''<br>[[Cholecystitis ultrasound#Chronic Calculous and Acalculous Cholecystitis|TAUSG]]<BR>[[Cholecystitis CT#Chronic Calculous and Acalculous Cholecystitis|CT abdomen]]<br>[[Cholecystitis other diagnostic studies#Chronic Cholecystitis|HIDA scan]]<br>[[Cholecystitis other diagnostic studies#Chronic Cholecystitis|Cholecystokinin stimulated HIDA scan]]</div>}} | ||
{{familytree | | | | | | | | | |!| | | |!| | | |!| |!| |!| | | | | | | | | | |}} | {{familytree | | | | | | | | | |!| | | |!| | | |!| |!| |!| | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | C01 |-| C02 | | C03 |'| C04 | | | | | | | | | | | | |C01=<div style="float: left; text-align: left; line-height: 150% ">'''Examine the patient:'''<BR>❑ Febrile<BR>❑ Tachycardia<BR>❑ Dehydrated<BR>❑ Abdominal guarding<BR>❑ [[Murphy's sign]]<BR>❑ Abdominal crepitations<BR>❑ Abdominal tenderness<BR>❑ Reduced bowel sounds<BR>❑ Increased bowel sounds<BR>❑ Abdominal distension<BR>❑ [[Sepsis physical examination|Signs of sepsis]]</div>|C02=Consider DDx of '''acute acalculous cholecystitis'''|C03=Consider DDx of '''chronic cholecystitis'''|C04=<div style="float: left; text-align: left; line-height: 150% ">'''Uncomplicated chronic cholecystitis:'''<br> | {{familytree | | | | | | | | | C01 |-| C02 | | C03 |'| C04 | | | | | | | | | | | | |C01=<div style="float: left; text-align: left; line-height: 150% ">'''Examine the patient:'''<BR>❑ Febrile<BR>❑ Tachycardia<BR>❑ Dehydrated<BR>❑ Jaundice<BR>❑ RUQ mass<BR>❑ Abdominal guarding<BR>❑ [[Murphy's sign]]<BR>❑ Abdominal crepitations<BR>❑ Abdominal tenderness<BR>❑ Reduced bowel sounds<BR>❑ Increased bowel sounds<BR>❑ Abdominal distension<BR>❑ [[Sepsis physical examination|Signs of sepsis]]</div>|C02=Consider DDx of '''acute acalculous cholecystitis'''|C03=Consider DDx of '''chronic cholecystitis'''|C04=<div style="float: left; text-align: left; line-height: 150% ">'''Uncomplicated chronic cholecystitis:'''<br> | ||
Elective cholecystectomy<br> | Elective cholecystectomy<br> | ||
'''Complicated chronic cholecystitis:'''<br> | '''Complicated chronic cholecystitis:'''<br> |
Revision as of 21:58, 10 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]
Cholecystitis
Definitions
Terms | Definitions |
---|---|
Cholecystitis | Cholecystitis is an inflammatory disease of the gallbladder. |
Acute cholecystitis | Acute cholecystitis is an acute inflammatory disease of the gallbladder, most often attributable to gallstones.[1][2] |
Acute calculous cholecystitis | Acute calculous cholecystitis is an acute inflammatory disease of the gallbladder in the presence of cholelithiasis.[1] The Tokyo guidelines is used in the diagnosis of acute calculous cholecystitis.[3][4] |
Acute acalculous cholecystitis | Acute acalculous cholecystitis is an acute necroinflammatory disease of the gallbladder in the absence of cholelithiasis and has a multifactorial pathogenesis.[5] Data from multiple studies is used for suspecting the diagnosis of acute acalculous cholecystitis.[5] |
Chronic cholecystitis | Chronic cholecystitis is a chronic inflammatory disease of the gallbladder with histological evidence of chronic inflammation like large range of related inflammatory epithelial changes including mononuclear infiltrate, fibrosis, thickening of muscular layer, dysplasia, hyperplasia and metaplasia.[6] |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Shown below is a diagram depicting the management of cholecystitis according to the Society for Surgery of the Alimentary Tract (SSAT),[8] the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES),[9] Tokyo guidelines for management of cholecystitis,[10] and review of data from multiple studies on acalculous cholecystitis.[5]
Characterize the symptoms ❑ Abdominal pain | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Acute RUQ or epigastric pain ❑ Sharp, severe and steady pain ❑ Pain associated with Sx suggestive of Mirizzi syndrome
❑ Pain associated with Sx suggestive of gallstone ileus | ❑ Acute vague abdominal pain ❑ RUQ mass ❑ Jaundice ❑ Fever | ❑ Recurrent biliary type abdominal pain ❑ Recurrent abdominal bloating ❑ Unstable stool with constipation/diarrhea ❑ Weight loss | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Febrile ❑ Tachycardia ❑ Dehydrated ❑ Jaundice ❑ RUQ mass ❑ Abdominal guarding ❑ Murphy's sign ❑ Abdominal crepitations ❑ Abdominal tenderness ❑ Reduced bowel sounds ❑ Increased bowel sounds ❑ Abdominal distension ❑ Signs of sepsis | Consider DDx of acute acalculous cholecystitis | Consider DDx of chronic cholecystitis | Uncomplicated chronic cholecystitis: Elective cholecystectomy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order laboratory tests: ❑ CBC ❑ BMP ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Amylase ❑ Lipase | No GBS/GB edema | Consider evaluation for alternate diagnosis of abdominal pain | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order urgent transabdominal USG (TAUSG) | GBS w/o GB edema/GB edema w/o GBS | HIDA scan | GB opacity visualized | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GBS w/ GB edema | GB opacity not visualized | CT abdomen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic criteria:[3][4] ❑ Local symptoms & signs
❑ Systemic signs ❑ Imaging findings | Diagnostic criteria:[5] ❑ Acute abdominal pain ❑ Fever ❑ Leukocytosis ❑ Abnormal liver function tets ❑ Imaging based criteria | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
W/ significantly elevated total bilirubin, alkaline phosphatase, ALT, AST &/or GGT | Consider evaluation for alternate diagnosis like choledocholithiasis & cholangitis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acute calculous cholecystitis w/ or w/o complications | Suspect acute acalculous cholecystitis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Hospital admission ❑ NPO ❑ IVF & correct electrolyte abnormalities ❑ Empiric IV antibiotics[11]
or
❑ Acute pain management | Immediate biliary drainage | Patient does not improve | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Grade 1 (Mild) | Grade 2 (Moderate) | Grade 3 (Severe) | Patient improves | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cholecystectomy within 72 hours | W/o complications & non high risk surgical candidates: Immediate cholecystectomy + blood C&S ± bile C&S W/o complications & high risk surgical candidates: Immediate biliary drainage + blood C&S ± bile C&S W/ complications: Emergency cholecystectomy + blood C&S ± bile C&S ± appropriate surgeries for gallstone ileus & Mirizzi syndrome | Emergency biliary drainage + blood C&S ± bile C&S | Urgent cholecystectomy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cholecystectomy after 3 months if GBS found during biliary drainage | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
†ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMP: Basic Metabolic Profile; C&S: Culture & Sensitivity; CA: Carcinoma; CBC: Complete Blood Count; CT: Computed Tomography; DDx: Differential Diagnosis; GB: Gallbladder; GBS: Gallbladder stone; GGT: Gamma-glutamyl transpeptidase; HIDA scan: Hepatobiliary Iminodiacetic Acid scan; IV: Intravenous; IVF: Intravenous fluids; NPO: Nil Per Oral; RUQ: Right Upper Quadrant; Sx: Symptom; W/: With; W/O: Without
Do's
- Antibiotics should be administered if infection is suspected on the basis of laboratory and clinical findings (>12,500 white cells/mm 3 or temperature >38.5°C) and radiographic findings (e.g., air in the gallbladder or gallbladder wall) as per the Infectious Diseases Society of America recommendation.[11]
- Prophylactic antibiotics before surgery
- Should be administered in highrisk patients (age >60 years, presence of diabetes, acute colic within 30 days of operation, jaundice, acute cholecystitis, or cholangitis). (Level I, Grade B)
- Should be limited to a single preoperative dose given within 1 hour of skin incision. (Level II, Grade A)
- Early laparoscopic cholecystectomy is the preferred approach and should be done in patients with acute cholecystitis. (Level II, Grade B)
- Radiographically guided percutaneous cholecystostomy is the effective method of biliary drainage and should be done in critically ill patients with acute cholecystitis, until the patient recovers sufficiently to undergo cholecystectomy. (Level II, Grade B)
- Time to discharge after surgery for patients with acute cholecystitis should be determined on an individual basis. (Level III, Grade A)
Dont's
- Antibiotics are not required in low-risk patients undergoing laparoscopic cholecystectomy. (Level I, Grade A)
- Drains are not required after elective laparoscopic cholecystectomy, and their use may increase complication rates. (Level I, Grade A)
Levels of Evidence and Scales Used for Recommendation Grading
The levels of evidence and scales used for recommendation grading is as follows.[9]
Levels of evidence and scales for grading | Definition |
---|---|
Level I | Evidence from properly conducted randomized, controlled trials |
Level II | Evidence from controlled trials without randomization or Cohort or case–control studies or Multiple time series, dramatic uncontrolled experiments |
Level III | Descriptive case series, opinions of expert panels |
Grade A | Based on high-level (level I or II), well-performed studies with uniform interpretation and conclusions by the expert panel |
Grade B | Based on high-level, well-performed studies with varying interpretation and conclusions by the expert panel |
Grade C | Based on lower-level evidence (level II or less) with inconsistent findings and/or varying interpretations or conclusions by the expert panel |
References
- ↑ 1.0 1.1 Strasberg, SM. (2008). "Clinical practice. Acute calculous cholecystitis". N Engl J Med. 358 (26): 2804–11. doi:10.1056/NEJMcp0800929. PMID 18579815. Unknown parameter
|month=
ignored (help) - ↑ Reiss, R.; Deutsch, AA. (1993). "State of the art in the diagnosis and management of acute cholecystitis". Dig Dis. 11 (1): 55–64. PMID 8443956.
- ↑ 3.0 3.1 Takada, T.; Kawarada, Y.; Nimura, Y.; Yoshida, M.; Mayumi, T.; Sekimoto, M.; Miura, F.; Wada, K.; Hirota, M. (2007). "Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis". J Hepatobiliary Pancreat Surg. 14 (1): 1–10. doi:10.1007/s00534-006-1150-0. PMID 17252291.
- ↑ 4.0 4.1 4.2 Hirota, M.; Takada, T.; Kawarada, Y.; Nimura, Y.; Miura, F.; Hirata, K.; Mayumi, T.; Yoshida, M.; Strasberg, S. (2007). "Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 78–82. doi:10.1007/s00534-006-1159-4. PMID 17252300.
- ↑ 5.0 5.1 5.2 5.3 Huffman, JL.; Schenker, S. (2010). "Acute acalculous cholecystitis: a review". Clin Gastroenterol Hepatol. 8 (1): 15–22. doi:10.1016/j.cgh.2009.08.034. PMID 19747982. Unknown parameter
|month=
ignored (help) - ↑ Zhou, D.; Guan, WB.; Wang, JD.; Zhang, Y.; Gong, W.; Quan, ZW. (2013). "A comparative study of clinicopathological features between chronic cholecystitis patients with and without Helicobacter pylori infection in gallbladder mucosa". PLoS One. 8 (7): e70265. doi:10.1371/journal.pone.0070265. PMID 23936177.
- ↑ Kimura, Y.; Takada, T.; Kawarada, Y.; Nimura, Y.; Hirata, K.; Sekimoto, M.; Yoshida, M.; Mayumi, T.; Wada, K. (2007). "Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMID 17252293.
- ↑ Duncan, CB.; Riall, TS. (2012). "Evidence-based current surgical practice: calculous gallbladder disease". J Gastrointest Surg. 16 (11): 2011–25. doi:10.1007/s11605-012-2024-1. PMID 22986769. Unknown parameter
|month=
ignored (help) - ↑ 9.0 9.1 Overby, DW.; Apelgren, KN.; Richardson, W.; Fanelli, R.; Overby, DW.; Apelgren, KN.; Beghoff, KR.; Curcillo, P.; Awad, Z. (2010). "SAGES guidelines for the clinical application of laparoscopic biliary tract surgery". Surg Endosc. 24 (10): 2368–86. doi:10.1007/s00464-010-1268-7. PMID 20706739. Unknown parameter
|month=
ignored (help) - ↑ Mayumi, T.; Someya, K.; Ootubo, H.; Takama, T.; Kido, T.; Kamezaki, F.; Yoshida, M.; Takada, T. (2013). "Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis". J UOEH. 35 (4): 249–57. PMID 24334691. Unknown parameter
|month=
ignored (help) - ↑ 11.0 11.1 Solomkin, JS.; Mazuski, JE.; Baron, EJ.; Sawyer, RG.; Nathens, AB.; DiPiro, JT.; Buchman, T.; Dellinger, EP.; Jernigan, J. (2003). "Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections". Clin Infect Dis. 37 (8): 997–1005. doi:10.1086/378702. PMID 14523762. Unknown parameter
|month=
ignored (help)